On Tuesday, Shares of Micron Technology, Inc. (NASDAQ:MU), gained 2.28% to $14.38, after the memory chip maker was upgraded to outperform from market perform at Wells Fargo. Analyst David Wong said while there are still “many near risks for Micron in particular and the memory industry in general,” he upgraded the stock because there is now “upside potential” to his valuation range. That range of $16 to $19 was 14% to 35% above Monday’s closing price of $14.06, which was the lowest close since Sept. 3, 2013. Meanwhile, Wong lowered his full-year 2015 earnings-per-share estimate to $2.31 from $2.38, and his 2016 estimate to $1.10 from $1.35, because of the decline in dynamic random-access memory pricing over the last few weeks.
Micron Technology, Inc. is a global provider of semiconductor devices. Through the Company’s global operations, it manufactures and markets a full range of Dynamic Random Access Memory (DRAM), NAND Flash and NOR Flash memory, as well as other memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products.
Shares of AbbVie Inc (NYSE:ABBV), inclined 0.53% to $52.78, during its last trading session.
AbbVie declared that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved VIEKIRAX® (ombitasvir/paritaprevir/ritonavir), as a new interferon and ribavirin-free treatment option for adult patients with chronic genotype 1 (GT1) hepatitis C virus (HCV) infection, counting those with compensated liver cirrhosis.1 VIEKIRAX comprises of a 12-week, two direct-acting antiviral, fixed-dose combination of paritaprevir/ritonavir with ombitasvir, dosed once daily.
Japan has one of the highest rates of hepatitis C infection in the industrialized world, with about 1.5 to 2 million people living with HCV. Genotype 1 is the most common HCV genotype in Japan with 60 to 70 percent of patients infected and, of those, about 95 percent are infected with the genotype 1b (GT1b) sub-type.
The approval is supported by the Phase 3 GIFT-I study. An overall 95 percent (n=140/148) of treatment-naïve and 94 percent (n=102/109) of treatment-practiced GT1b HCV infected patients achieved SVR12 with VIEKIRAX.
AbbVie Inc. (AbbVie) is a global, research-based biopharmaceutical company. The Company develops and markets therapies that address a range of diseases. The Company’s products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn’s disease; hepatitis C (HCV); human immunodeficiency virus (HIV); endometriosis; thyroid disease; Parkinson’s disease; complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone.
Shares of Walt Disney Co (NYSE:DIS), inclined 0.95% to $99.43, during its last trading session.
Walt Disney will discuss fiscal full year and fourth quarter 2015 financial results via a live audio webcast starting at 5:00 p.m. EST / 2:00 p.m. PST on Thursday, November 5, 2015.
Results will be released at about 4:15 p.m. EST / 1:15 p.m. PST.
The Walt Disney Company together with its subsidiaries and affiliates is a diversified international family entertainment and media enterprise with five business segments: media networks, parks and resorts, studio entertainment, consumer products and interactive media.
Finally, JetBlue Airways Corporation (NASDAQ:JBLU), ended its last trade with -1.14% loss, and closed at $25.19.
After successfully launching the first Havana-bound flight on a major airline from New York since travel restrictions were eased this year, JetBlue (JBLU) and Cuba Travel Services (CTS) recently declared the addition of a second JetBlue charter flight connecting the two cities with nonstop service. The expansion of the JetBlue-CTS plan comes shortly after the U.S. further eased restrictions by allowing approved travelers to Cuba to travel with close relatives.
The roundtrip charter flight between New York’s John F. Kennedy International Airport (JFK) and Havana’s José Martí International Airport (HAV) will operate every Tuesday startning December 1, 2015. The existing JetBlue-CTS flight operates every Friday, giving New York customers more flexibility in their travel plans.
JetBlue has doubled its number of charter flights to Cuba since travel restrictions have eased, and is the only major airline operating charter flights from New York.
JetBlue Airways Corporation is a passenger carrier company. The Company provides air transportation services across the United States, Caribbean and Latin America.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
